Patent Claims and the Article "A": Only One or More Than One And Other Impactful Words/Punctuation
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent counsel on the impact of recent decisions addressing "a" and the implications of these decisions on U.S. patent practice. The panel will offer best practices of fundamentally sound principles to prepare and prosecute a U.S. patent application to avoid careless claim terminology and untoward language in the specification.
Outline
- Analysis of cases where "a" meant "one or more"
- Analysis of cases where "a" meant "one and only one"
- Supreme Court decision and revelation of just how big a deal "a" can be
- Best practices for preparing and prosecuting patent applications, echoing that sometimes it is not most important to write to be understood, but to write in such a way that the author cannot be misunderstood
Benefits
The panel will review these and other high profile issues:
- How can a single word/unfortunate punctuation in claim language and specification lead to the demise of U.S. patent rights?
- How do recent decisions impact drafting claims and specifications?
- What steps can counsel take to avoid careless claim terminology and mistakes in the specification?
Faculty
Krista Aiello
Assistant General Counsel-Patents
Unilever
Ms. Kostiew is an experienced patent attorney with a demonstrated history of working in the consumer goods industry... | Read More
Ms. Kostiew is an experienced patent attorney with a demonstrated history of working in the consumer goods industry including beauty and personal care products and compositions (bars, liquids, sanitizers, shampoos, conditioners, etc.). She is skilled in Patent Prosecution, Freedom to Operate (FTO), Patent Portfolio Analysis, Patent Law, Technology Transfer, NDA/CDAs, and other aspects of Intellectual Property.
CloseDr. Paul W. Browning, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Browning focuses on patent litigation and appeals. He has led teams as first chair at trial, at Markman... | Read More
Dr. Browning focuses on patent litigation and appeals. He has led teams as first chair at trial, at Markman proceedings, and on appeal. His litigation experience includes taking and cross examining witnesses at trial, briefing and arguing dispositive motions, drafting appellate briefs, and arguing cases on appeal. He has also managed day-to-day litigation activities in actions involving multiple parties. In addition, he advises clients on patent matters, including coordination of prosecution and U.S. and foreign litigation strategy.
CloseAdriana L. Burgy
Partner
Finnegan Henderson Farabow Garrett & Dunner
Ms. Burgy focuses on opinion work, client counseling, patent prosecution and management, and litigation in the... | Read More
Ms. Burgy focuses on opinion work, client counseling, patent prosecution and management, and litigation in the chemical, pharmaceutical, and biotechnology arts. She counsels her clients on a diverse range of patent issues. She assists clients on single-patent issues as well as complex matters involving multiple patents and applications requiring ongoing advice on patent portfolio strategy and development, with an eye towards litigation. From a patent prosecution perspective, she has drafted and prosecuted numerous patent applications domestically and internationally, guided and advised clients on complex procedural and legal issues surrounding clients' patent portfolios, developed and implemented strategic prosecution in support of ongoing litigation, generated strategies for maximizing investment in patent portfolios, and facilitated the identification of high-priority applications within patent portfolios.
CloseThomas L. Irving
Partner
The Marbury Law Group
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.
Close